Inherited prethrombotic disorders and infectious purpura

Thrombosis and Haemostasis

Volumn 75, Issue 6, 1996, Pages 899-901

  Westendorp, Rudi G J ^a   Reitsma, Pieter H ^a   Bertina, Regier M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTEIN C; ANTITHROMBIN; BLOOD CLOTTING FACTOR 5; PROTEIN C; PROTEIN S;

ADULT; ARTICLE; GENE MUTATION; GENETIC RISK; HUMAN; INFANT; MAJOR CLINICAL STUDY; MENINGOCOCCOSIS; PRIORITY JOURNAL; PURPURA; THROMBOSIS;

EID: 0029905929     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0038-1650391     Document Type: Article

References (24)

1. Laursen B, Faber V, Brock A, Gormsen J, Sorensen. Disseminated intravascular coagulation, antithrombin III and complement in meningococcal infections. Acta Med Scan 1981; 209: 221-7.
2. Ledere F, Hazelzet J, Jude B, Hofhuis, W, Hue V, Martinet A, Van der Voort E. Protein C and S deficiency in severe infectious purpura of children: a collaborative study of 40 cases. Intensive Care Med, 1992; 18: 202-5.
3. Powars D, Larsen R, Johnson J, Hulbert T, Sun T, Patch MJ, Francis R, Chan L. Epidemic meningococcemia and purpura fulminans with induced protein C deficiency. Clin Infect Dis 1993; 17: 254-61.
4. Fijnvandraat K, Derkx B, Peters M, Bijlmer R, Sturk A, Prins MH, van Deventer SJH, ten Gate JW. Coagulation activation and tissue necrosis in meningococcal septic shock: Severely reduced protein C levels predict a high mortality. Thromb Haemost 1995; 73: 15-20.
5. Taylor FB, Chang A, Esmon CT, D'Angelo A, Vigano-D'Angelo S, Blick KE. Protein C prevents the coagulopathic and lethal effects of Escherichia coli infusion in the baboon. J Clin Invest 1987; 79: 918-25.
6. Taylor FB, Chang A, Ferrell G, Mather T, Catlett R, Blick K, Esmon CT. C4b-Binding protein excerbates the host response to Escherichia coli. Blood 1991; 78: 357-63.
7. Redens TB, Emerson TE. Antithrombin III treatment limits disseminated intra-vascular coagulation in endotoxemia. Circ Shock 1989; 28: 49-58.
8. Bertina RM, Koeleman RPC, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, van der Velden PA, Reitsma PH. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369: 64-7.
9. Svensson PJ, Dahlbäck B. Resistance to activated protein C as a basis for venous thrombosis. N Engl J Med 1994; 330: 517-22.
10. Perkins WP, Downie I, Keefe M, Chisholm M. Cutaneous necrosis in pregnancy secondary to activated protein C in hereditary angioedema. J Roy Soc Med 1995; 88: 229-30.
11. Westendorp RGJ, Langermans JAM, de Bel CE, Meinders AE, Vandenbroucke JP, van Furth R, van Dissel JT. Release of tumor necrosis factor: An innate host characteristic that may contribute to the outcome of meningococcal disease. J Infect Dis 1995; 171: 1057-60.
12. Tait RC, Walker ID, Reitsma PH, Islam SIAM, McCall F, Poort SR, Conkie JA, Bertina RM. Prevalence of Protein C deficiency in the healthy population. Thromb Haemost 1995; 73: 87-93.
13. Deutz-Terlouw PP, Ballering L, van Wijngaarden A, Bertina RM. Two ELISA's for measurement of protein S, and their use in the laboratory diagnosis of protein S deficiency. Clin Chim Acta 1990; 186; 321-34.
14. Tait RC, Walker ID, Islam SIAM, McCall F, Conlie JA, Wight M, Mitchell R, Davidson JF. Protein C activity in healthy volunteers - Influence of age, sex, smoking and oral contraceptives. Thromb Haemost 1993; 70: 281-5.
15. de Ronde H, Bertina RM. Laboratory diagnosis of APC-resistance: a critical evaluation of the test and the development of diagnostic criteria. Thromb Haemost 1994; 72: 880-6.
16. Ferguson JH, Chapman OD. Fulminating meningococcal infections and the so-called Waterhouse-Friderichsen syndrome. Am J Path 1947; 24: 763-95.
17. Hardman JM. Fatal meningococcal infections: The changing pathologic picture in the '60s. Military Medicine 1968; 12: 951-64.
18. Böhm N. Adrenal, cutaneous and myocardial lesions in fulminating endotoxinemia. Path Res Pract 1982; 174: 92-105.
19. Moore KL, Andreoli SP, Esmon N, Esmon CT, Bang NU. Endotoxin enhances tissue factor and suppresses thrombomodulin expression of human vascular endothelium in vitro. J Clin Invest 1987; 79: 124-30.
20. Koster T, Rosendaal FR, Briët E, van der Meer FJM, Colly LP, Trienekens PH, Poort SR, Reitsma PH, Vandenbroucke JP. Protein C deficiency in a controlled series of unselected outpatients: an infrequent but clear risk factor for venous thrombosis. The Leiden Thrombophilia study. Blood 1995; 85: 2756-61.
21. Tait RC, Walker ID, Perry DJ, Islam SIAM, Daly ME, McCall F, Conkie JA, Carrell RW. Prevalence of antithrombin deficiency in the healthy pop: ulation. Br J Haematol 1994; 87: 106-12.
22. Rivard GE, David M, Farrell C, Schwarz HP. Treatment of purpura fulminans in meningococcemia with protein C concentrate. J Pediatr 1995; 426: 646-52.
23. Brandtzaeg P, Kierulf P, Gaustad P, Skulberg A, Bruun JN, Halvorsen S, Sorensen E. Plasma endotoxin as a predictor of multiple organ failure and death in systemic meningococcal disease. J Inf Dis 1989; 159: 195-204.
24. Girardin E, Roux-lombard P, Grau CE, Suter P, Gallati H, the J5 study group, Dayer J-M. Imbalance between tumour necrosis factor-alpha and soluble TNF receptor concentrations in severe meningococcaemia. Immunology 1992; 76: 20-3.